Last reviewed · How we verify
Autologous Platelet-Rich Fibrin
Autologous Platelet-Rich Fibrin is a Biologic drug developed by National Children's Medical Center, Uzbekistan. It is currently in Phase 1 development.
At a glance
| Generic name | Autologous Platelet-Rich Fibrin |
|---|---|
| Sponsor | National Children's Medical Center, Uzbekistan |
| Modality | Biologic |
| Phase | Phase 1 |
Approved indications
Common side effects
Key clinical trials
- Clinical Comparison of Alb-PRF vs PRF on Postoperative Morbidity Following FGG Harvesting (NA)
- Comparison of Hyaluronic Acid, Injectable Platelet-Rich Fibrin, and Prolotherapy in TMJ Arthrocentesis (NA)
- Efficacy of Platelet-rich-Fibrin Gel in Patients With Chronic Leg Ulcers (EARLY_PHASE1)
- Evaluation of Revitalization Success Using i-PRF in Non-Surgical Root Canal Retreatment (NA)
- REGENFAST vs L-PRF in Periodontal Regeneration (EARLY_PHASE1)
- Bone Regeneration Using PRF After Cyst Enucleation (NA)
- Guided Lateral Sinus Lifting Using Autologous Serum Albumin/Platelet-Rich Fibrin (NA)
- Effect of Injectable Platelet Rich Derivatives on Orthodontic Canine Retraction (NA)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Autologous Platelet-Rich Fibrin CI brief — competitive landscape report
- Autologous Platelet-Rich Fibrin updates RSS · CI watch RSS
- National Children's Medical Center, Uzbekistan portfolio CI
Frequently asked questions about Autologous Platelet-Rich Fibrin
What is Autologous Platelet-Rich Fibrin?
Autologous Platelet-Rich Fibrin is a Biologic drug developed by National Children's Medical Center, Uzbekistan.
Who makes Autologous Platelet-Rich Fibrin?
Autologous Platelet-Rich Fibrin is developed by National Children's Medical Center, Uzbekistan (see full National Children's Medical Center, Uzbekistan pipeline at /company/national-children-s-medical-center-uzbekistan).
What development phase is Autologous Platelet-Rich Fibrin in?
Autologous Platelet-Rich Fibrin is in Phase 1.